Establishment Labs Holdings Inc. (ESTA) Financial Ratios
10 years of historical data (2016–2025) · Healthcare · Medical - Devices
EV/EBITDA
N/A
—
5yr avg: N/A
P/FCF
N/A
—
5yr avg: N/A
P/B Ratio
↑
106.69
↑+132% vs avg
5yr avg: 46.02
30Y Low6.8·High91.7
ROE
↓
-133.3%
↓+71% vs avg
5yr avg: -465.3%
30Y Low-353%·High-65%
Debt/EBITDA
N/A
—
5yr avg: N/A
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
ESTA Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Establishment Labs Holdings Inc. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $2.5B | $2.2B | $1.3B | $663M | $1.6B | $1.6B | $878M | $568M | $476M | — | — |
| Enterprise Value | $2.7B | $2.3B | $1.4B | $815M | $1.7B | $1.6B | $846M | $579M | $445M | — | — |
| P/E Ratio → | -49.31 | — | — | — | — | — | — | — | — | — | — |
| P/S Ratio | 11.81 | 10.23 | 7.81 | 4.01 | 9.93 | 12.79 | 10.36 | 6.34 | 7.77 | — | — |
| P/B Ratio | 106.69 | 91.68 | 24.44 | 36.03 | — | 31.93 | 11.71 | 14.34 | 6.85 | — | — |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
ESTA EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 11.12 | 8.63 | 4.93 | 10.63 | 12.80 | 9.99 | 6.46 | 7.28 | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — | — | — | — |
ESTA Profitability
Margins and return-on-capital ratios measuring operating efficiency
Establishment Labs Holdings Inc. earns an operating margin of -18.5%. Operating margins have expanded from -39.4% to -18.5% over the past 3 years, signaling improving operational efficiency. A negative ROE of -133.3% indicates the company is currently destroying shareholder equity.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 69.3% | 69.3% | 66.0% | 64.8% | 65.9% | 67.4% | 62.0% | 61.3% | 59.0% | 51.0% | 51.0% |
| Operating Margin | -18.5% | -18.5% | -30.1% | -39.4% | -24.5% | -19.8% | -33.0% | -34.5% | -39.0% | -57.6% | -80.0% |
| Net Profit Margin | -24.2% | -24.2% | -51.0% | -47.5% | -46.5% | -32.5% | -45.0% | -42.6% | -34.5% | -100.6% | -111.9% |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -133.3% | -133.3% | -236.7% | -1537.7% | -353.5% | -65.5% | -66.5% | -69.9% | -65.4% | — | — |
| ROA | -14.5% | -14.5% | -27.5% | -32.7% | -42.9% | -27.8% | -27.9% | -32.7% | -24.3% | -80.5% | -75.0% |
| ROIC | -14.6% | -14.6% | -20.9% | -35.4% | -38.0% | -39.9% | -44.9% | -51.8% | -75.6% | -154.1% | -105.7% |
| ROCE | -14.1% | -14.1% | -20.4% | -33.9% | -28.4% | -21.1% | -24.9% | -32.0% | -47.8% | — | — |
ESTA Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Net debt stands at $189M ($264M total debt minus $76M cash).
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 11.23 | 11.23 | 4.24 | 10.45 | — | 1.07 | 0.70 | 1.22 | 0.32 | — | — |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| Net Debt / Equity | — | 8.02 | 2.54 | 8.27 | — | 0.02 | -0.43 | 0.27 | -0.44 | — | — |
| Net Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| Debt / FCF | — | — | — | — | — | — | — | — | — | — | — |
| Interest Coverage | -1.30 | -1.30 | -3.06 | -4.11 | -5.19 | -3.38 | -3.06 | -3.31 | -1.37 | -2.34 | -5.45 |
ESTA Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
Establishment Labs Holdings Inc.'s current ratio of 3.04x is well above the 1.0 safety threshold, indicating strong short-term liquidity with ample room to cover current liabilities. The quick ratio of 2.00x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.04 | 3.04 | 3.56 | 3.06 | 3.85 | 3.55 | 5.11 | 4.12 | 6.05 | 0.69 | 0.23 |
| Quick Ratio | 2.00 | 2.00 | 2.41 | 1.67 | 2.91 | 2.66 | 4.21 | 2.89 | 4.54 | 0.46 | 0.14 |
| Cash Ratio | 0.92 | 0.92 | 1.32 | 0.70 | 1.70 | 1.68 | 3.26 | 1.62 | 3.20 | 0.19 | 0.01 |
| Asset Turnover | — | 0.59 | 0.48 | 0.61 | 0.77 | 0.91 | 0.54 | 0.77 | 0.53 | 0.61 | 0.67 |
| Inventory Turnover | 0.76 | 0.76 | 0.72 | 0.73 | 1.51 | 1.45 | 1.39 | 1.21 | 1.01 | 1.29 | 2.02 |
| Days Sales Outstanding | — | 134.01 | 142.90 | 103.69 | 79.96 | 70.41 | 82.45 | 92.78 | 105.24 | 137.96 | 122.55 |
ESTA Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Establishment Labs Holdings Inc. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | — | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | — | — | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — | — |
| Shares Outstanding | — | $30M | $28M | $26M | $24M | $24M | $23M | $21M | $17M | $18M | $18M |
Peer Comparison
Compare ESTA with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 ESTAYou | $2B | -49.3 | — | — | 69.3% | -18.5% | -133.3% | -14.6% | — |
 ALGN | $13B | 32.2 | 15.2 | 26.6 | 68.3% | 15.3% | 10.4% | 15.4% | 0.1 |
 INMD | $849M | 9.4 | 6.5 | 10.1 | 78.5% | 23.0% | 13.5% | 13.5% | 0.2 |
 AEYE | $79M | -25.2 | 224.1 | 16.8 | 78.3% | -7.9% | -43.2% | -20.1% | 34.1 |
 ATEC | $1B | -9.2 | 4120.9 | 480.4 | 69.6% | -10.7% | -630.7% | -12.6% | 1425.2 |
 NVCR | $2B | -11.7 | — | — | 74.5% | -23.5% | -38.9% | -16.4% | — |
 XTNT | $62M | 14.7 | 5.9 | 6.1 | 62.9% | 5.4% | 10.6% | 8.1% | 2.3 |
 SYK | $118B | 36.6 | 21.2 | 27.5 | 64.0% | 19.5% | 15.1% | 11.4% | 2.4 |
 ZBH | $17B | 24.8 | 9.8 | 11.7 | 61.6% | 16.5% | 5.6% | 5.4% | 3.1 |
 BSX | $67B | 23.3 | 20.8 | 18.4 | 69.0% | 19.8% | 12.4% | 8.8% | 3.3 |
 MDT | $102B | 22.0 | 14.5 | 19.6 | 65.3% | 17.8% | 9.4% | 6.0% | 3.2 |
| Healthcare Median | — | 22.1 | 14.2 | 18.5 | 63.9% | -4.3% | -32.6% | -11.6% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 10 years · Updated daily
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare
ESTA — Frequently Asked Questions
Quick answers to the most common questions about buying ESTA stock.
What is Establishment Labs Holdings Inc.'s P/E ratio?
Establishment Labs Holdings Inc.'s current P/E ratio is -49.3x. This places it at the 50th percentile of its historical range.
What is Establishment Labs Holdings Inc.'s ROE?
Establishment Labs Holdings Inc.'s return on equity (ROE) is -133.3%. The historical average is -141.5%.
Is ESTA stock overvalued?
Based on historical data, Establishment Labs Holdings Inc. is trading at a P/E of -49.3x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
What are Establishment Labs Holdings Inc.'s profit margins?
Establishment Labs Holdings Inc. has 69.3% gross margin and -18.5% operating margin.